President Biden diagnosed with ‘rebound COVID’

Joe Biden rebound COVID

President Biden tests positive for COVID again, will return to isolation – CBS News

President Joe Biden has tested positive for COVID-19 again but has experienced “no relapse of symptoms” and will not resume treatment, the White House said. Biden has canceled plans to go to his home in Delaware Sunday and Michigan on Tuesday.

Biden tested positive for COVID again and was quarantined to keep others safe. He was still working and would get back out there shortly.

A positive Covid-19 test for Biden was found on Saturday, and the White House is working to ensure social distancing for public events.

Biden, 79, first tested positive for Covid-19 on July 21 and underwent a five-day course of Paxlovid to treat his illness.

Mayo Clinic researchers studied the effects of a five-day oral regimen of nirmatrelvir and ritonavir, marketed jointly as Paxlovid, on high-risk patients with COVID-19. The treatment was beneficial for all patients enrolled in the trial.

We found that relapse was unusual among this patient population and that all four individuals that experienced relapse recovered rapidly and without further COVID-directed treatment.

Researchers believe that a secondary immune response to the SARS-CoV-2 virus might have caused minor symptoms of COVID-19 in four patients who had received vaccinations for over 90 days prior to becoming infected.

The CDC said that relapses of Covid-19 are rare and that most cases involve mild illnesses. They said there were no reports of severe illnesses, and more research is needed to determine who is at the most significant risk.

For more coverage on this story, check the following additional news sources:

John Nightbridge is a veteran reporter, researcher, and economic policy major from UCLA. Passionate about world issues and potential ways to solve them is a significant focus of his work. Writing freelance and reading the news are John's passions at work. Outside of work, it's all about sky diving, surfing, and stock market modeling.